Table 3.
Laboratory data.
| All = patients | Age<18 | Age≥18 | P value | |
|---|---|---|---|---|
| (n = 67) | (n = 25) | (n = 42) | ||
| Leukocyte counts (×109/L) | 9563 ± 5.84 | 11.64 ± 8.26 | 8.36 ± 3.30 | 0.068 |
| Erythrocyte counts (×1012/L) | 4.39 ± 0.49 | 4.48 ± 0.41 | 4.33 ± 0.52 | 0.233 |
| Hemoglobin (g/L) | 128 (118.1–142.9) | 124 (119.85–135) | 132 (118–144.35) | 0.218 |
| Lymphocyte count (×109/L) | 1.96 ± 0.99 | 2.14 ± 1.19 | 1.86 ± 0.86 | 0.268 |
| Glucose (mmol/L) | 4.93 ± 1.12 | 5.02 ± 1.20 | 4.88 ± 1.09 | 0.612 |
| Total protein (g/L) | 66.63 ± 5.99 | 68.81 ± 4.77 | 65.33 ± 6.31 | 0.013* |
| Total bilirubin (μmol/L) | 8.00 ± 4.65 | 6.0 ± 2.19 | 9.19 ± 5.30 | 0.001* |
| Uric acid (μmol/L) | 257.61 ± 84.72 | 246.60 ± 100.54 | 264.17 ± 74.28 | 0.452 |
| Creatinine (μmol/L) | 54.51 ± 16.44 | 41.96 ± 15.96 | 61.98 ± 11.53 | 0.000* |
| Total cholesterol (mmol/L) | 3.79 ± 0.96 | 3.57 ± 0.45 | 3.92 ± 1.10 | 0.114 |
| Triglycerides (mmol/L) | 1.23 ± 0.82 | 1.21 ± 0.66 | 1.24 ± 0.91 | 0.892 |
| High-density lipoprotein (mmol/L) | 1.19 ± 0.32 | 1.17 ± 0.25 | 1.20 ± 0.36 | 0.687 |
| Low-density lipoprotein (mmol/L) | 2.29 ± 0.72 | 2.07 ± 0.53 | 2.42 ± 0.80 | 0.055 |
| ESR (mm/h) | 10 (6–17) | 11 (6–16.5) | 8.65 (5.875–18.25) | 0.484 |
| CRP (mg/L) | 1.82 (0.5–4.7) | 1 (0.425–5.23) | 2.705 (0.975–4.385) | 0.248 |
| FT3 (pmol/L) | 4.88 ± 0.97 | 5.04 ± 1.15 | 4.78 ± 0.85 | 0.323 |
| FT4 (pmol/L) | 13.06 ± 2.86 | 13.59 ± 2.73 | 12.74 ± 2.92 | 0.243 |
| TSH (pmol/L) | 2.02 ± 1.35 | 1.68 ± 1.11 | 2.22 ± 1.45 | 0.114 |
| Homocysteine levels (μmol/L) | 14.74 ± 6.30 | 15.31 ± 6.56 | 14.40 ± 6.19 | 0.574 |
| Folic acid (ng/mL) | 7.59 ± 4.02 | 6.60 ± 3.21 | 8.19 ± 4.36 | 0.119 |
| Vitamin B12 (pg/mL) | 591.76 ± 397.33 | 614.66 ± 367.69 | 578.14 ± 417.72 | 0.719 |
| ANAs positive | 17 (25.4) | 3 (12.0) | 14 (33.3) | 0.081 |
| Thyroid peroxidase/Thyroglobulin antibodies positive | 7 (10.4) | 3 (12.0) | 4 (9.5) | 1.000 |
| Intracranial pressure (mmH2O) | 160 (135–180) | 150 (135–170) | 165 (140–200) | 0.048* |
| CSF leukocyte counts (×106/L) | 12 (4–32) | 15 (4.5–42) | 11 (3.75–30.5) | 0.266 |
| CSF protein concentration (mg/L) | 309.8 (233.2–388.9) | 238 (183.55–306) | 361.15 (294.525–446.875) | 0.000* |
| Positive oligoclonal band | 8 (11.9) | 5 (20.0) | 3 (7.1) | 0.138 |
| CSF anti-NMDAR(+) | 3 (.4.5) | 1 (4.0) | 2 (4.8) | 1.000 |
| Serum AQP4-IgG(+) | 0 | 0 | 0 | – |
Data are presented as mean ± standard deviation, number (percentage), or median (interquartile range).
NLR, neutrophil-to-lymphocyte ratio; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormones; ANAs, antinuclear antibodies; CSF, cerebrospinal fluid; anti-NMDAR, anti-N-methyl-D-aspartate receptor; AQP4-IgG, aquaporin-4 immunoglobulins G.
*P < 0.05.